To obtain information on whether CPOT investigations were consistent with the mission of the HIDTA program, we reviewed the Office of National Drug Control Policy Reauthorization Act of 1998, ONDCP’s appropriations statutes and accompanying committee reports, ONDCP’s strategic plans and policies, and ONDCP’s Web site. We also reviewed all HIDTA applications (38) to ONDCP from HIDTAs that received discretionary funds for various investigation activities linked to the CPOT list in fiscal years 2002 and 2003, and compared them with the mission of the HIDTA program. At 11 selected HIDTA sites—Appalachia; Atlanta; Central Florida; Lake County, Indiana; Los Angeles; Milwaukee; Nevada; North Texas; Oregon; Rocky Mountain; and Washington-Baltimore—we interviewed HIDTA management officials and task force leaders to discuss whether their investigative activities were consistent with the HIDTA mission. We selected these 11 HIDTAs to ensure geographic spread (east coast, central, west coast) across the country. To obtain information about ONDCP’s distribution of CPOT funding, we interviewed ONDCP officials and obtained statistics they provided on HIDTAs that received CPOT funding in fiscal years 2002, 2003, and 2004 (app.I). We also reviewed ONDCP documents and correspondence that described the basis for ONDCP’s decision for awarding HIDTAs CPOT funding. In addition, we discussed with officials at three HIDTAs— Washington-Baltimore, North Texas, and Los Angeles—how CPOT funding was being used. We selected these three HIDTAs because they had received funds for both fiscal years 2002 and 2003 and were geographically dispersed. We also interviewed officials from 8 of the 13 HIDTAs (Appalachia, Atlanta, Central Florida, Lake County, Milwaukee, Nevada, Oregon, and Rocky Mountain) that did not apply for or applied for but did not receive CPOT funding in fiscal years 2002 and 2003. We selected these HIDTAs to reflect broad geographic segments of the country. We determined that the data presented in appendixes I and II from ONDCP, the Organized Crime Drug Enforcement Task Force (OCDETF), the Drug Enforcement Administration (DEA), and the Federal Bureau of Investigation (FBI) are sufficiently reliable, for the purposes of this review, based on interviews with agency officials and a review of their information systems documentation. In 1988, Congress established the White House’s Office of National Drug Control Policy to, among other things, coordinate the efforts of federal drug control agencies and programs and establish the HIDTA program. By fiscal year 2004, ONDCP had designated 28 drug trafficking areas (HIDTAs) as centers of illegal drug production, manufacturing, importation, or distribution within the United States with a federally funded HIDTA program budget of about $225 million. Each HIDTA is to develop and implement an annual strategy to address the regional drug threat. The initiatives involve the active participation of federal, state, and local law enforcement agencies to enhance and assist the coordination of drug trafficking control efforts in the region. To encourage HIDTAs to conduct CPOT investigations, ONDCP utilized discretionary funding. In fiscal year 2004, ONDCP allocated about $8 million in discretionary funding to HIDTAs to support their drug initiatives that link with international drug trafficking organizations on the CPOT list. This funding is not meant to supplant or replace existing agency/program budgets intended for similar purposes, according to ONDCP guidance to the HIDTAs. OCDETF is a nationwide law enforcement task force program administered within Justice that targets major narcotic trafficking and money laundering organizations using the combined resources and expertise of its federal member agencies together with state and local investigators. Its mission is to identify, investigate, and prosecute members of high-level drug trafficking enterprises and to dismantle or disrupt the operations of those organizations. To help carry out this mission and to focus investigative resources on major sources of supply, OCDETF member agencies developed the CPOT list of major international drug trafficking organizations. In September 2002, at the request of the U.S. Attorney General, OCDETF issued the first CPOT list, naming international drug trafficking organizations most responsible for supplying illegal drugs to the United States. OCDETF member agencies developed criteria for determining whether an international drug organization was to be placed on the CPOT list. Criteria include whether the international organization operates nationwide in multiple regions of the United States and deals in substantial quantities of illegal drugs or illicit chemicals on a regular basis that have a demonstrable impact on the nation’s drug supply. OCDETF compiles and issues the CPOT list at the beginning of each fiscal year, with the intent that federal law enforcement agencies will target their investigations on CPOT organizations. OCDETF member agencies control the CPOT list and its distribution. OCDETF also collaborates with ONDCP on reviews of CPOT funding applications by HIDTAs that link their initiatives with the CPOT list. CPOT investigations were not inconsistent with the mission of the HIDTA program because HIDTAs’ targeting of local drug traffickers linked with international organizations on the CPOT list was one possible strategy for achieving the program’s goal of eliminating or reducing significant sources of drug trafficking in their regions. The mission of the HIDTA program is not expressly stated in current law. However, ONDCP has developed a mission statement that reflects the legislative authority for the HIDTA program, specifically, to enhance and coordinate U.S. drug control efforts among federal, state, and local law enforcement agencies to eliminate or reduce drug trafficking and its harmful consequences in critical regions of the United States. The primary legislative authority for the HIDTA program is the Reauthorization Act, which provides guidance on the mission of the program by setting out factors for the Director of ONDCP to consider in determining which regions to designate as HIDTAs. The factors contained in the act are the extent to which 1. the area is a center of illegal drug production, manufacturing, importation, or distribution; 2. state and local law enforcement have shown a determination to respond aggressively to drug trafficking in the area by committing resources to respond to it; 3. drug-related activities in the area are having a harmful impact in other areas of the country; and 4. a significant increase in federal resources is necessary to respond adequately to drug-related activities in the area. In addition, House and Senate Appropriations Committee reports on ONDCP’s appropriations have stated that the program was established to provide assistance to federal, state, and local law enforcement entities operating in those areas most adversely affected by drug trafficking. The use of a portion of the HIDTA program’s discretionary funds to focus on CPOT investigations is not inconsistent with ONDCP’s mission statement for the program and the legislative authority on which it is based, particularly the first and third factors in the Reauthorization Act. Drug traffickers operating in a HIDTA may be linked with the CPOT list because of their role in major international drug trafficking activities, including illegal distribution in multiple regions of the United States. Given such activities, they would contribute to the HIDTA’s status as a center of illegal drug importation and distribution and have a harmful impact in other regions. Similarly, in keeping with appropriations committee statements on the purpose of the program, HIDTA involvement in CPOT investigations is one way of assisting federal, state, and local operations in areas where the significant adverse effects of drug trafficking activities are due in part to links to international criminal organizations. Thus, for HIDTAs to investigate and disrupt or dismantle regional drug traffickers that are linked with CPOT organizations is not inconsistent with the HIDTA program’s stated mission and its legislative authority. ONDCP distributed discretionary funds to HIDTAs to help support their investigations of drug traffickers linked with international organizations on the CPOT list by reviewing and approving HIDTA applications for funding. In fiscal years 2002, 2003, and 2004, ONDCP distributed CPOT funds to a total of 17 of the 28 HIDTAs. A Justice official who participates in the evaluation of HIDTA applications for CPOT funding said that ONDCP encourages applications for CPOT funding where additional funds are likely to benefit an initiative and move the investigation forward. Some HIDTAs chose not to apply because they face a domestic drug threat that does not have a link to any international CPOT organization activity. Other HIDTAs that have applied for funds did not receive CPOT funding because they did not have sufficient investigative resources to uncover the link to a CPOT organization. In commenting on a draft of this report, Justice said that while this may be true in some circumstances, it was also often the case that HIDTAs may have had sufficient resources but simply had not yet taken the investigation far enough to justify the award of discretionary funds. During fiscal years 2002 and 2003, 6 HIDTAs did not apply and 7 applied but were not approved for CPOT funding. In fiscal year 2004, 17 of the 28 HIDTAs did not receive CPOT funding—10 did not apply and 7 applied but were not approved for funding. ONDCP and HIDTA officials mentioned several reasons why some HIDTAs may not receive funding. First, some HIDTAs were denied funding if the investigative activities in their funding applications were not consistent with the HIDTA mission and linked to a CPOT organization. Second, ONDCP did not provide clear guidance or sufficient information for HIDTAs to develop their applications for CPOT funds, although it took steps to clarify its guidance and create opportunity for all HIDTAs to participate.